The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.
Click on the button below to create your account and get immediate access to thousands of articles.
China's commitment to global growth, cooperation "reassuring": GSK CEO
It was encouraging to see China "championing a new kind of economic globalization" based on innovation, fairness and openness, said British pharmaceutical giant GlaxoSmithKline (GSK) Plc CEO Andrew Witty.
January22,2017
GSK, INNOVAX and Xiamen University to jointly develop next-generation cervical cancer vaccine
INNOVAX, a subsidiary of China's YangShengTang Group, and Xiamen University signed a global alliance partnership agreement on Friday with British pharmaceutical giant GlaxoSmithKline (GSK) in Wavre, Belgium, to develop a next-generation vaccine against human papillomavirus (HPV).
September07,2019
Shanghai Fosun Pharma's subsidiary to buy GlaxoSmithKline plant
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. will spend up to 250 million yuan (36 million U.S. dollars) to buy GlaxoSmithKline's Suzhou pharmaceutical factory in east China, according to a Fosun statement released Tuesday.
July10,2019
China to cut prices of expensive patent drugs
China's health authority on Friday announced cuts of over 50 percent in the prices of three patent drugs.
May23,2016
China's 2nd Import Expo attracts over 250 Fortune 500 companies, industry leaders
More than 250 Fortune 500 companies and industry leaders have signed up for the second China International Import Expo (CIIE), the organizer said Thursday.
May10,2019
If you have any questions, please enter them in the box below.
Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.
Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.
